Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Avenue Therapeutics Inc (ID) ATXI

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also... see more

Current News ()

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

GlobeNewswire November 6, 2025

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

GlobeNewswire November 6, 2025

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire November 14, 2024

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

GlobeNewswire October 9, 2024

Avenue Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire September 3, 2024

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire August 13, 2024

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire August 9, 2024

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire June 20, 2024

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

GlobeNewswire May 16, 2024
View More News ››

Opinion & Analysis ()

FDA Approval of Biopharma's Pain Drug Expected This Year

Streetwise Reports February 20, 2020

Understanding Fortress Biotech

Streetwise Reports February 6, 2020

Biopharma Agrees to $215 Million Acquisition Deal

Streetwise Reports November 23, 2018

Coverage Initiated on Biopharma with 'Opioid Sparing Solution for Post-Op Pain'

Streetwise Reports June 28, 2018
View More Opinion ››

Bullboard Posts ()

Big buying going on for this stock this morning.

It's a good one to buy and hold for the year.
coolfooldumbguy - January 24, 2025

ATXI.... It's a "new game" post RS

I'll call this ........... "The Next One" ; )
Iseneschal - May 8, 2024

ATXI...... Re-read this NR again !

Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates 2023-03-08 13:01 ET - News Release MIAMI,...
Iseneschal - March 9, 2023

ATXI.....broke $1.18 to the upside.... Bullish!

On watch for continuation to N.H.O.D....... Lets see if it goes? Cheers !
Iseneschal - March 9, 2023

ATXI .... In PB mode support at $1.10

No position
Iseneschal - March 9, 2023

ATXI .... On watch for yesterdays NR.....no position

Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates 2023-03-08 13:01 ET - News Release MIAMI,...
Iseneschal - March 9, 2023
View more Bullboard ››

Green Bridge Metals Corporation

Green Bridge Metals Corporation

Green Bridge Metals Corporation engages in the acquisition, exploration, and development of mining projects in Canada. The ...
View More »

Podcasts